Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Chng

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Biomed Research International|July 17, 2014
p53 abnormalities and potential therapeutic targeting in multiple myelomaP J Teoh, W J Chng
Singapore Medical Journal|August 27, 2005
Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospitalW J Chng, C Sum, P Kuperan
Singapore Medical Journal|March 10, 2004
An audit of fresh frozen plasma usage in an acute general hospital in SingaporeW J Chng, M K Tan, Ponnudurai Kuperan
Clinical and Laboratory Haematology|February 3, 2005
Haematological parameters in severe acute respiratory syndromeW J Chng, H C Lai, A Earnest, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
Genetic events in the pathogenesis of multiple myelomaW J Chng, O Glebov, P L Bergsagel, et al.
Leukemia|November 10, 2012
Fas apoptosis inhibitory molecule is upregulated by IGF-1 signaling and modulates Akt activation and IRF4 expression in multiple myelomaJ Huo, S Xu, B Lin, et al.
The British Journal of Radiology|August 6, 1999
Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancerJ A Spencer, W J Chng, E Hudson, et al.
Leukemia|July 22, 2015
MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomibZ Xie, C Bi, J Y Chooi, et al.
Leukemia|December 17, 2015
Gene signature combinations improve prognostic stratification of multiple myeloma patientsW J Chng, T-H Chung, S Kumar, et al.
Leukemia|March 15, 2014
p53 haploinsufficiency and functional abnormalities in multiple myelomaP J Teoh, T H Chung, S Sebastian, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Biomed Research International|July 17, 2014
p53 abnormalities and potential therapeutic targeting in multiple myelomaP J Teoh, W J Chng
Singapore Medical Journal|August 27, 2005
Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospitalW J Chng, C Sum, P Kuperan
Singapore Medical Journal|March 10, 2004
An audit of fresh frozen plasma usage in an acute general hospital in SingaporeW J Chng, M K Tan, Ponnudurai Kuperan
Clinical and Laboratory Haematology|February 3, 2005
Haematological parameters in severe acute respiratory syndromeW J Chng, H C Lai, A Earnest, et al.
Best Practice & Research. Clinical Haematology|December 12, 2007
Genetic events in the pathogenesis of multiple myelomaW J Chng, O Glebov, P L Bergsagel, et al.
Leukemia|November 10, 2012
Fas apoptosis inhibitory molecule is upregulated by IGF-1 signaling and modulates Akt activation and IRF4 expression in multiple myelomaJ Huo, S Xu, B Lin, et al.
The British Journal of Radiology|August 6, 1999
Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancerJ A Spencer, W J Chng, E Hudson, et al.
Leukemia|July 22, 2015
MMSET regulates expression of IRF4 in t(4;14) myeloma and its silencing potentiates the effect of bortezomibZ Xie, C Bi, J Y Chooi, et al.
Leukemia|December 17, 2015
Gene signature combinations improve prognostic stratification of multiple myeloma patientsW J Chng, T-H Chung, S Kumar, et al.
Leukemia|March 15, 2014
p53 haploinsufficiency and functional abnormalities in multiple myelomaP J Teoh, T H Chung, S Sebastian, et al.
Pageof 4